兽医诊断市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00003079
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 261
Buy Now

【研究报告】兽医诊断市场规模预计将从2022年的40.455亿美元增长到2030年的72.7043亿美元;预计 2022 年至 2030 年复合年增长率为 7.60%。
分析师观点
兽医诊断市场分析解释了市场驱动因素,例如人畜共患疾病患病率上升和伴侣动物拥有量增加等。此外,兽医诊断领域精准医学的出现预计将在 2022 年至 2030 年期间引入市场新趋势。根据产品,兽医诊断市场分为仪器和消耗品。 2022年,仪器细分市场将占据较大份额。从疾病类型来看,传染病细分市场占据最大份额,占据市场主导地位。按动物类型细分,伴侣动物细分市场可能在预测期内占据兽医诊断市场的相当大份额。根据最终用户,兽医医院和诊所预计将在 2022 年至 2030 年期间占据兽医诊断市场的最大份额。
兽医诊断解决方案有助于快速识别牛、猪等各种动物的健康状况、绵羊和山羊。兽医诊断对于动物健康至关重要,可以在发现健康问题之前识别健康问题,并支持更快的诊断和治疗计划。传统的兽医诊断分析血液、组织、尿液或粪便,以检测蛋白质、抗体、疾病存在或整体健康的一般指标。基于实验室的测试可确保准确的质量结果,而护理点诊断可实现实时决策,从而减轻忧心忡忡的动物主人的负担。
战略见解
市场见解
人畜共患病患病率上升
人畜共患疾病不仅会导致动物患病,还会导致人类患病。这些感染可能会导致从轻微到严重的病症。根据美国疾病控制与预防中心的数据,到 2023 年,人类每 10 种传染病中就有 6 种是由动物传播的,而 4 种新发或新出现的传染病中有 3 种是由动物传播的。
根据外交关系委员会的数据人畜共患疾病每年在全球造成 25 亿人患病和 270 万人死亡,占已知传染病的 60% 和新发传染病的 75%。根据欧洲疾病预防和控制中心的数据,弯曲菌病是报告最多的人畜共患疾病,2021 年有 127,840 例,而 2020 年为 120,946 例。沙门氏菌病是第二常见的人畜共患疾病,2021 年有 60,050 例,而 2020 年为 52,702 例。 2020 年。其他常见的人畜共患病包括雅尼尼病(6,789 例)、产志贺毒素大肠杆菌感染(6,084 例)和李斯特菌病(2,183 例)。
根据世界卫生组织 (WHO) 的数据,狂犬病发生在超过 150 例中每年造成数万人死亡,特别是在亚洲和非洲。其中,约 40% 是 15 岁以下的儿童。猫、牛和狗是美国报道最多的患有狂犬病的家畜。此外,99% 的狂犬病人类传播都是由狗造成的,也是人类狂犬病死亡的主要来源。狗介导的狂犬病造成的经济负担估计为每年 86 亿美元。国际畜牧研究所估计,印度每年有 13 种人畜共患疾病导致 24 亿人类疾病和 220 万人死亡。根据国家医学图书馆(NLM)发表的一篇文章,埃塞俄比亚、尼日利亚、坦桑尼亚和印度的人畜共患疾病负担最高,且疾病广泛传播。此外,印度每年报告约 20,000 人死于狂犬病。因此,全球范围内不断上升的狂犬病增加了对疾病诊断的需求,从而促进了兽医诊断市场的增长。
根据全球真菌感染行动 (GAFFI),估计每年会发生约 40,000 例孢子丝菌病全球范围内的一年。根据 NLM 上发表的一篇文章,孢子丝菌病是由单一主导分子物种引起的,即南美洲东南部 88% 的孢子丝菌病是由巴西链球菌引起的,而南美洲西部、中部和北美则为 89%,94 % 的澳大利亚和南非以及 99.3% 的亚洲是由球形链球菌引起的。因此,全球人畜共患疾病患病率的上升加速了对兽医诊断的需求。
未来趋势
兽医诊断中精准医学的出现
精准医学正在彻底改变兽医护理领域,提供量身定制的诊断和治疗,可能有益于动物福利和健康。精准医学使兽医能够利用基因组测序、个性化诊断和靶向治疗提供更准确的诊断、定制治疗和改善结果。基因组测序、基因编辑和靶向治疗等技术的快速进步将继续推动兽医护理领域精准医学的进步。通过开发更复杂的工具和技术来更精确地诊断和治疗动物,预计将增强对动物遗传学的了解。由于兽医护理中的精准医学,可以及早识别出患有某些疾病风险的动物,并实施有针对性的干预措施。通过这种积极主动的方法,可以在治疗最有效的初始阶段预防或检测疾病。
此外,可以使用精准医学根据动物的遗传特征制定营养策略。兽医专业人员可以根据动物独特的营养需求和遗传变异来优化饮食,以支持动物健康、预防疾病并提高性能。作为精准医学的结果,可以通过识别与所需性状和疾病风险相关的基因来实现选择性育种实践。有了这些知识,育种者就可以做出更好的育种决策,减少遗传性疾病的发生,并增加动物种群的遗传多样性。因此,兽医护理中的精准医疗可以推动兽医诊断市场的未来增长。
报告细分和范围
基于产品的见解
根据产品,兽医诊断市场分为仪器和消耗品。仪器细分市场在 2022 年占据更大的市场份额。消耗品细分市场预计在 2022 年至 2030 年期间将录得显着的复合年增长率。兽医耗材包括测试管、容器、培养皿、深孔板以及包括注射器、针头、安全刺血针、静脉注射装置和管以及采样器的套件。这些耗材旨在用于宠物(犬、猫和禽)、牛、山羊、猪、马和家禽等伴侣动物诊断。试管涉及柠檬酸盐、ESR、葡萄糖等。这些比色皿用于伴侣动物的生化测试。此外,一些制造商还参与为兽医诊断动物提供耗材。 HWTAI 就是这样的一个例子。 HWTAI提供的耗材包括标本容器、培养皿、深孔板、比色皿、拭子、VTM等。兽医和伴侣动物诊断测试的不断增加导致对消耗品的高需求,从而刺激了 2022 年至 2030 年消耗品领域的市场。
基于技术的见解
基于技术,全球兽医诊断市场正在增长细分为免疫诊断、临床生物化学、血液学、分子诊断和其他兽医诊断技术。免疫诊断部分进一步细分为侧流分析、ELISA 测试、免疫分析仪、过敏原特异性免疫诊断测试和其他免疫诊断。临床生化部分进一步细分为临床化学分析、血糖监测、血气和电解质。免疫诊断领域在 2022 年占据最大的市场份额,预计 2022-2030 年复合年增长率最高。动物的健康主要与寄生虫病有关。具有两个宿主猎物-捕食者生命周期的寄生虫充当中间宿主,导致人类和动物中一些最具破坏性和最普遍的疾病。根据世界卫生组织 (WHO) 2023 年报告,每年约有 10 亿例病例和数百万人因人畜共患病死亡。其中,全球报告的新发传染病中约60%为人畜共患病。为了克服如此高的人畜共患病感染率,兽医对免疫诊断技术的需求很高。囊型包虫病 (CE) 和泡型包虫病 (AE) 是由多房棘球绦虫幼虫期(后生虫)引起的严重人畜共患疾病。免疫诊断学采用抗原-抗体结合和多种检测方法来形成免疫复合物。此外,免疫诊断技术比其他技术(例如用于药物定量的 PCR 色谱法)更容易执行。此外,免疫诊断学可用于研究兽医动物的传染病血清学。辉瑞动物保健公司提供的“WITNESS”免疫诊断就是这样的例子之一。 WITNESS 测试提供准确、快速的结果,无需折断,具有室温可存储性,并且易于解释。 WITNESS HW 心丝虫测试适用于狗和猫,具有准确度、经济性和最短的测试时间。此外,WITNESS 猫白血病病毒 (FeLV) 检测非常准确、灵敏且具有特异性,适用于检测任何年龄段的猫或小猫。随着人畜共患疾病患病率的上升,兽医对免疫诊断的需求很高,从而加速了免疫诊断领域的市场发展。
基于动物类型的见解
就动物类型而言,兽医诊断市场分为牲畜和动物伴侣动物。畜牧动物进一步细分为牛、猪、家禽和其他畜牧动物。伴侣动物进一步细分为狗、猫、马和其他伴侣动物。伴侣动物细分市场在 2022 年占据更大的市场份额,预计 2022 年至 2030 年复合年增长率将更高。
伴侣动物包括狗、猫、马等。伴侣动物是人类和食用动物传染病的潜在来源。新城疫流行病学中的新孢子虫病是伴侣动物患传染病的一个常见例子。此外,西尼罗河病毒 (WNV) 会导致大脑炎症(脑炎)和脊髓内膜炎症(脑膜炎)。在被携带蚊子叮咬的马中,三分之一通常会患上严重疾病,导致动物死亡。猫传染性腹膜炎(FIP)是一种由猫冠状病毒引起的猫病毒性疾病。根据 Thermo Fisher Scientific 的报告,这种疾病的发病率为每 5,000 个猫科动物中就有 1 例。由于患病率如此之高,兽医对伴侣动物诊断方法的需求很高,最终推动了伴侣动物市场的发展。
还采取了各种举措来提高兽医对抗菌药物对伴侣的效用的了解动物。 AVMA 调查显示,兽医对使用抗菌药物治疗伴侣动物疾病的认识表明,60.5% 的美国兽医参与者了解与抗菌药物使用相关的指南。这些指南与人们对治疗伴侣动物传染病的抗菌药物的认识不断提高有关,进一步促进了该细分市场的市场。
基于疾病类型的见解
按疾病类型,市场分为传染病和非传染性疾病疾病。传染病细分市场在 2022 年占据更大的市场份额,预计 2022 年至 2030 年兽医诊断市场的复合年增长率将更高。
基于最终用户的见解
最终用户细分市场为兽医医院和诊所、动物诊断实验室以及兽医研究机构和大学。兽医医院和诊所细分市场在 2022 年占据最大的市场份额,预计 2022 年至 2030 年兽医诊断市场的复合年增长率最高。
按产品划分的兽医诊断市场 – 2022 年和 2030 年
区域分析< br>北美兽医诊断市场分为美国、加拿大和墨西哥。该地区的市场增长归因于传染性动物疾病的增加——这是一个积极影响市场增长的独立因素。此外,监测设备的技术进步进一步促进了整体市场的增长。
根据美国疾病控制与预防中心 (CDC) 的报告,与动物有关的肠道疾病估计导致 450,000 例疾病、5,000 例住院治疗和 76 例死亡仅在美国每年。细菌和寄生虫是唯一报告的病因类型。例如,“隐孢子虫”是已确认的单一病因暴发的最常见原因,在美国造成 21 起暴发,其次是沙门氏菌,2020 年有 18 起(35%)。在美国,某些兽医诊断受到监管和依赖正在美国农业部兽医生物制品中心 (USDA-CVB) 审批。这些涉及兽医诊断试剂盒,旨在诊断接受治疗的动物中的病原体。 USDA-CVB 是用于检测猫白血病病毒 (FeLV)、犬细小病毒、犬恶丝虫和其他病毒的即时诊断。
美国与动物接触相关的肠道疾病爆发
No.1。爆发次数
No.疾病
病因
确诊病因 (CE)
疑似病因 (SE)
总计
确诊病因 (CE)
疑似病因 (SE)
总计
细菌



沙门氏菌
18
2
20
1237
6
1243
E。大肠杆菌
10
0
10
70
0
70
弯曲杆菌
2
3
5
13
11< br>24
小计
30
5
35
1320
17
1337



寄生
< br>

隐孢子虫
21
3
24
158
23
181
小计
21
3
24
158
23
181



总计
51
8
59
1478
140
1518

没有。住院人数
人数死亡人数
病因
确诊病因 (CE)
疑似病因 (SE)
总计
确诊病因 (CE)
疑似病因 (SE)
总计
细菌



沙门氏菌
286
0
286
2
0
2
E。大肠杆菌
18
0
18
1
0
1
弯曲杆菌
0
0
0
0
0< br>0
小计
304
0
304
3
0
3



寄生
< br>

隐孢子虫
6
2
8
0
0
0
小计
6
2
8
0
0
0



总计
310
2
312
3
0
3
来源:美国卫生与公众服务部
因此,诊断方法主要涉及克服动物感染的高流行率。据美国兽医实验室诊断师协会 (AAVLD) 称,至少有 500 名州和联邦政府资助的病理学家和诊断学家为美国和加拿大的大型动物群健康监测做出了贡献。此外,根据美国疾病控制与预防中心 (CDC) 检索到的数据,以食用动物为重点的诊断实验室获得了超过 1 亿美元的资金来进行监测,以研究可能在 2020 年影响畜牧业的高影响疾病。因此,早期识别新出现的病原体有助于控制动物疾病感染和识别潜在的人畜共患病。因此,上述因素对北美兽医诊断市场产生积极影响。
根据农业、渔业和林业部的报告,通过蚊子传播的日本脑炎(JE)病毒对猪的繁殖性能产生负面影响;它还会导致人类病毒性脑炎。 2022年,澳大利亚爆发了家猪中的乙脑病毒疫情,昆士兰州、新南威尔士州(NSW)、维多利亚州和南澳大利亚州的80多家猪场均检测到了乙型脑炎病毒。 2022 年 3 月,澳大利亚首次爆发乙脑病毒,导致澳大利亚宣布为国家重大传染病事件 (CDINS)。澳大利亚有能力继续管理乙脑病毒风险。例如,2023 年 6 月,CDINS 宣布 JEV 爆发,国家已做好充分准备,以专门的应对措施应对未来的疫情爆发。
公共科学图书馆 (PLoS) 报告称,传染病的发病率有所增加自 2020 年以来,亚太地区出现了这种情况。例如,农场对野生动物栖息地的侵占不断增加,导致牲畜和野生动物的范围扩大,从而加速了野生动物新出现的传染病/人畜共患疾病的严重后果。因此,亚太地区新发疾病战略受益于控制动物传染病的流行。在区域和全球范围内,联合国粮食及农业组织 (FAO)、世界动物卫生组织 (OIE) 和在亚太地区开展工作的世界卫生组织都密切关注人畜共患疾病。根据《加速亚太地区同一个健康》报告,由于生态系统退化、生物多样性丧失和气候变化给亚洲人类与动物环境界面带来公共卫生挑战,“同一个健康”方法的概念和重要性正受到广泛关注。太平洋。因此,采用“同一个健康”方法可以帮助亚太国家通过多个部门和利益相关者的参与取得进展。这些活动涉及人类健康、陆地和水生动物健康以及粮食生产,以最终改善实现可持续发展目标 (SDG) 所必需的成果。
该报告介绍了全球兽医诊断市场的领先参与者。其中包括 Thermo Fisher Scientific Inc、Idex Laboratories Inc、Zoetis Inc、Heska Corp、Neogen Corp、Randox Laboratories Ltd、Virbac SA、INDICAL BIOSCIENCE GmbH、FUJIFILM Holdings Corp 和 Merck Animal Health。
2023 年 4 月,玛氏完成收购Heska 是先进兽医诊断和专业解决方案的全球提供商。 Heska 现在是玛氏宠物护理科学与诊断部门的一部分,能够更广泛地覆盖诊断和技术,同时加速研发并扩大全球宠物医疗保健解决方案的使用范围。2023 年 8 月,硕腾推出了首款农场乳腺炎诊断。 Zoetis 已在欧洲多个市场推出了 Vetscan Mastigram+,这是一种快速的农场乳腺炎诊断方法。它使用简单的流量试纸测试在八小时内检测出革兰氏阳性乳腺炎,从而在下次挤奶之前获得结果。由于通常只有革兰氏阳性病例才会受益于抗菌药物的治疗,因此农民或兽医可以利用此信息提供更有针对性的治疗公司简介
Thermo Fisher Scientific Inc Idexx Laboratories Inc Zoetis Inc Heska Corp Neogen Corp Randox Laboratories Ltd Virbac SA INDICAL BIOSCIENCE GmbH FUJIFILM Holdings Corp Merck Animal Health
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the veterinary diagnostics market across the globe?

Key factors that are driving the growth of this market are rising prevalence of zoonotic disease and growing ownership of companion animals are expected to boost the market growth for the veterinary diagnostics over the years.

What is veterinary diagnostics?

Veterinary diagnostics are critical for animal health, identifying health issues that they are otherwise able to detect and supportive faster diagnosis and treatment planning. Traditional diagnosis analyzes blood, tissues, urine, or stool to detect proteins, antibodies, disease presence, or general indicators of overall health. These analyses are a cornerstone of veterinary care.

What is the market CAGR value of veterinary diagnostics market during forecast period?

The CAGR value of the veterinary diagnostics market during the forecasted period of 2020-2030 is 7.60%.

Which disease type segment leads the veterinary diagnostics market?

The infectious disease segment held the largest share of the market in the global veterinary diagnostics market and held the largest market share of 62.18% in 2022.

Which end user held the largest share in the veterinary diagnostics market?

The veterinary hospital & clinics segment dominated the global veterinary diagnostics market and held the largest market share of 52.15% in 2022.

Which region is expected to witness significant demand for veterinary diagnostics market in the coming years?

Global veterinary diagnostics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share of the veterinary diagnostics market in 2022. With several European market players focusing on research and development activities in the field of imaging technology, the regional market for veterinary diagnostics market is likely to propel in Europe region during the forecast period.

Which are the top companies that hold the market share in veterinary diagnostics market?

Thermo Fisher Scientific and Zoetis, Inc. are the top two companies that hold huge market shares in the veterinary diagnostics market.

Who are the key players in the veterinary diagnostics market?

The veterinary diagnostics market majorly consists of the players such Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Zoetis Inc, Heska Corp, Neogen Corp, Randox Laboratories Ltd, Virbac SA, INDICAL BIOSCIENCE GmbH, FUJIFILM Holdings Corp, and Merck Animal Health.

The List of Companies - Veterinary Diagnostics Market

  1. Thermo Fisher Scientific Inc            
  2. Idexx Laboratories Inc       
  3. Zoetis Inc                
  4. Heska Corp            
  5. Neogen Corp        
  6. Randox Laboratories Ltd                   
  7. Virbac SA                
  8. INDICAL BIOSCIENCE GmbH            
  9. FUJIFILM Holdings Corp    
  10. Merck Animal Health

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports